IL10 and rheumatoid arthritis: The average increase in MFI of LAMR1 following IL-10 treatment on monocytes of healthy individuals were 14.1 ± 3.3%, 75.4 ± 9.7% and 99.5 ± 7.1% at 4, 12 and 18 h timepoints respectively (Fig. 4B), and these were significantly higher than the 1.5 ± 3.7%, 22.8 ± 5.1% and 43.2 ± 7.0% increase observed in patients with RA (Fig. 4B).